Trials / Sponsors / Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promot Glioblastoma, IDH-wildtype | Phase 2 | 2024-09-02 |